dr. o'shaughnessy on breast cancer subtype-specific cytotoxic agents
Published 10 years ago • 337 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
1:35
dr. o'shaughnessy on the future of breast cancer treatment
-
2:04
dr. joyce o’shaughnessy on promising agents in triple-negative breast cancer
-
1:03
dr. o'shaughnessy on the future of tnbc treatment
-
1:40
dr. o'shaughnessy on the future of breast cancer biomarkers
-
1:22
dr. o'shaughnessy on the utility of capivasertib in targeting akt in breast cancer
-
2:09
dr. o'shaughnessy on using phosphoprotein assays to personalize treatment for breast cancer
-
1:47
dr. joyce o'shaughnessy on treatment with everolimus in advanced breast cancer
-
1:17
dr. o'shaughnessy on role of chemotherapy in future tnbc treatment
-
1:12
dr. o'shaughnessy on adding phosphoprotein testing to genomic testing for breast cancer
-
1:28
dr. o'shaughnessy on precision medicine in triple negative breast cancer
-
0:48
copy of dr. o’shaughnessy on clinical implications of the text and soft trials in breast cancer
-
2:08
dr. joyce o'shaughnessy on eribulin in metastatic breast cancer
-
1:44
dr. o'shaughnessy discusses negative tnbc iniparib trial results
-
1:52
dr. o’shaughnessy on the utility of tucatinib in the her2 breast cancer brain metastases
-
1:32
dr. o’shaughnessy on clinical implications of the text and soft trials in breast cancer
-
1:56
dr. o'shaughnessy on phosphoprotein assays for treatment decision-making for breast cancer
-
1:04
dr. joyce o'shaughnessy invites you the international congress on the future of breast cancer
-
41:55
headline news in breast cancer with dr. joyce o'shaughnessy
-
1:07
dr. o'shaughnessy on avastin as her standard of care